OWC Pharmaceutical Research Corp (OWCP)

[GP65]

One scenario: A run back up to .20-.25 through March/April with a RS for 25-1 potentially awaiting. That would make sense, pending approval, naturally. One major factor is that the company has said 'up to 500-1', which in my view was done to protect themselves in case the symbol dropped unexpected to trips. At this juncture, OWCP has many positives that longs can feel very good about.